Literature DB >> 2424861

Blood loss in prostatectomy. Comparison between injected and non-injected prostates.

M H Muzafer.   

Abstract

Minimizing blood loss in prostatic surgery is necessary for reducing mortality and morbidity. It is also essential to reduce the frequency of blood transfusion for its well-known risks and to reduce the costs.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 2424861     DOI: 10.1007/bf02082603

Source DB:  PubMed          Journal:  Int Urol Nephrol        ISSN: 0301-1623            Impact factor:   2.370


  8 in total

1.  The risk of abbreviating the major crossmatch in urgent or massive transfusion.

Authors:  H A Oberman; B A Barnes; B A Friedman
Journal:  Transfusion       Date:  1978 Mar-Apr       Impact factor: 3.157

2.  The significance of perineal pain after injection of the prostate.

Authors:  A C Broughton; P H Smith
Journal:  Br J Urol       Date:  1970-02

3.  Transperineal intraprostatic injection treatment of benign prostatic enlargement.

Authors:  G D Sharma; P P Goel
Journal:  Aust N Z J Surg       Date:  1977-04

4.  Optimal blood use in genitourinary surgery.

Authors:  A D Jenkins; P D Mintz
Journal:  J Urol       Date:  1981-10       Impact factor: 7.450

5.  A simple photometric method for determination of blood loss during transurethral surgery.

Authors:  H Jansen; O Berseus; J E Johansson
Journal:  Scand J Urol Nephrol       Date:  1978

6.  The treatment of benign prostatomegaly by injection.

Authors:  H B Salleh
Journal:  Aust N Z J Surg       Date:  1973-12

7.  Injection treatment of enlarged prostate.

Authors:  G L Talwar; S K Pande
Journal:  Br J Surg       Date:  1966-05       Impact factor: 6.939

8.  Blood loss during transurethral resection of the prostate.

Authors:  P H Abrams; P J Shah; K Bryning; C G Gaches; M H Ashken; N A Green
Journal:  Anaesthesia       Date:  1982-01       Impact factor: 6.955

  8 in total
  1 in total

1.  Blood loss during transurethral resection of the prostate injected with phenol solution.

Authors:  W Szewczyk
Journal:  Int Urol Nephrol       Date:  1991       Impact factor: 2.370

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.